BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9829727)

  • 1. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.
    Reiss K; D'Ambrosio C; Tu X; Tu C; Baserga R
    Clin Cancer Res; 1998 Nov; 4(11):2647-55. PubMed ID: 9829727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor.
    Hongo A; Yumet G; Resnicoff M; Romano G; O'Connor R; Baserga R
    Cancer Res; 1998 Jun; 58(11):2477-84. PubMed ID: 9622092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.
    Hongo A; Kuramoto H; Nakamura Y; Hasegawa K; Nakamura K; Kodama J; Hiramatsu Y
    Cancer Res; 2003 Nov; 63(22):7834-9. PubMed ID: 14633710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
    Chernicky CL; Yi L; Tan H; Gan SU; Ilan J
    Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors.
    Reiss K; Tu X; Romano G; Peruzzi F; Wang JY; Baserga R
    Clin Cancer Res; 2001 Jul; 7(7):2134-44. PubMed ID: 11448933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
    Vogt A; Wang AS; Johnson CS; Fabisiak JP; Wipf P; Lazo JS
    J Pharmacol Exp Ther; 2000 Feb; 292(2):530-7. PubMed ID: 10640289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
    Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
    Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.
    Resnicoff M; Coppola D; Sell C; Rubin R; Ferrone S; Baserga R
    Cancer Res; 1994 Sep; 54(18):4848-50. PubMed ID: 8069850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
    D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
    Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptide sequence from the C-terminus of the insulin-like growth factor-I receptor that induces apoptosis and inhibition of tumor growth.
    Reiss K; Yumet G; Shan S; Huang Z; Alnemri E; Srinivasula SM; Wang JY; Morrione A; Baserga R
    J Cell Physiol; 1999 Oct; 181(1):124-35. PubMed ID: 10457360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of IGF1R siRNA on the growth of human liver cancer SMMC7721 cell xenograft in nude mice].
    Niu J; Qian HX; Li XN; Han ZG
    Ai Zheng; 2007 Jul; 26(7):703-8. PubMed ID: 17626744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
    Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G
    Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro.
    Sekharam M; Nasir A; Kaiser HE; Coppola D
    Anticancer Res; 2003; 23(2B):1517-24. PubMed ID: 12820418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.